These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13647457)

  • 21. Idiopathic hypoprothrombinemia associated with hemorrhagic diathesis, and the effect of vitamin K.
    LEY AB; READER GG; SORENSON CW; OVERMAN RS
    Blood; 1951 Aug; 6(8):740-55. PubMed ID: 14858439
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of a small dose of vitamin K1 on the bilirubin level and the prothrombin time of the blood of premature infants].
    de BRUIJNE J
    Ned Tijdschr Geneeskd; 1960 Jun; 104():1229-32. PubMed ID: 13805222
    [No Abstract]   [Full Text] [Related]  

  • 23. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis.
    von Kries R; Hanawa Y
    Thromb Haemost; 1993 Mar; 69(3):293-5. PubMed ID: 8470054
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of a low dosage of vitamin K1 on the bilirubin content and the prothrombin-time of the blood in premature infants.
    de BRUIJNE J
    Biol Neonat; 1960 Apr; 2():49-55. PubMed ID: 13855598
    [No Abstract]   [Full Text] [Related]  

  • 25. [Apropos of the oral use of vitamin K 1 (konakion)].
    de VRIES S; de POTTER
    Rev Belg Pathol Med Exp; 1960 May; 27():164-8. PubMed ID: 13782240
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn.
    von Kries R; Göbel U
    Lancet; 1994 Feb; 343(8893):352. PubMed ID: 7905158
    [No Abstract]   [Full Text] [Related]  

  • 27. A CLINICAL RE-EVALUATION OF THE EFFECTIVENESS OF VITAMIN K1 IN ORAL SURGERY.
    MORGAN DH; CHRISTENSEN RW
    Am J Orthop; 1963 Jul; 5():202-5. PubMed ID: 14046039
    [No Abstract]   [Full Text] [Related]  

  • 28. [Considerations on the advisability of systematic prophylaxis of hemorrhagic disease of the newborn].
    Scianaro L; D'Elia R; Bellocchio E; Cassone L; Loiodice G
    Minerva Pediatr; 1981 Dec; 33(23):1139-42. PubMed ID: 7329385
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemorrhagic disease in a newborn due to inadequate vitamin K prophylaxis: case report.
    Su CT; Hung FC; Huang CB
    Chang Gung Med J; 2000 May; 23(5):309-13. PubMed ID: 10916233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which vitamin K preparation for the newborn?
    Drug Ther Bull; 1998 Mar; 36(3):17-9. PubMed ID: 9684416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemorrhagic disease of the newborn and vitamin K prophylaxis.
    Gnegy R
    W V Med J; 1973 Oct; 69(10):278-9. PubMed ID: 4584461
    [No Abstract]   [Full Text] [Related]  

  • 32. Change in hospital protocol regarding the use of vitamin K prophylaxis in newborns following a case of spontaneous subdural haematoma in a previously healthy 40-day-old infant.
    Boujan MM; Sharef KH
    East Mediterr Health J; 2013 May; 19(5):502-5. PubMed ID: 24617132
    [No Abstract]   [Full Text] [Related]  

  • 33. Congenital and familial hypoconvertinemias; synoptic review of literature and a presentation of a personal case sensible to vitamin K.
    AVOGARO P
    Acta Med Patav; 1956; 16(1):1-40. PubMed ID: 13339126
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of haemorrhagic disease of the newborn. Routine vitamin K1 administration is justified.
    Prescrire Int; 1998 Aug; 7(36):125-7. PubMed ID: 10342952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of menadione and vitamin K 1 in animal nutrition].
    BRUBACHER G; FRIESECKE H; STREIFF K; WISS O
    Int Z Vitaminforsch; 1959; 30():213-7. PubMed ID: 13805119
    [No Abstract]   [Full Text] [Related]  

  • 36. Parents' knowledge and perceptions regarding vitamin K prophylaxis in newborns.
    Eventov-Friedman S; Vinograd O; Ben-Haim M; Penso S; Bar-Oz B; Zisk-Rony RY
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):409-13. PubMed ID: 23242324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of vitamin K treatment in prophylaxis of hypoprothrombinemia of the newborn].
    BUKOVINSZKY L; BODIS L; PIUKOVICH I
    Magy Noorv Lapja; 1952 Feb; 15(2):45-52. PubMed ID: 14947161
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.
    Schubiger G; Stocker C; Bänziger O; Laubscher B; Zimmermann H
    Eur J Pediatr; 1999 Jul; 158(7):599-602. PubMed ID: 10412823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.
    Handel J; Tripp JH
    BMJ; 1991 Nov; 303(6810):1109. PubMed ID: 1747579
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical comparison of vitamin K1 and water-soluble vitamin K.
    GAMBLE JR; DENNIS EW; COON WW; HODGSON P; WILLS PW; MACRIS JA; DUFF IF
    AMA Arch Intern Med; 1955 Jan; 95(1):52-8. PubMed ID: 13217503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.